Cefixime + Cloxacillin + Lactic AcidThird Party Manufacturing in India

This fixed-dose combination brings together three active components with complementary mechanisms to provide broad-spectrum antimicrobial coverage, particularly for genitourinary and gynecological infections. Cefixime, a third-generation cephalosporin, inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins and disrupting the transpeptidation of peptidoglycan, leading to osmotic lysis of susceptible Gram-negative and Gram-positive bacteria. Cloxacillin is a penicillinase-resistant penicillin that also targets bacterial cell wall synthesis by binding to PBPs, but its key advantage is its resistance to staphylococcal beta-lactamase enzymes due to its bulky isoxazole side chain that sterically hinders the enzyme from accessing the beta-lactam ring. This makes cloxacillin particularly effective against penicillinase-producing staphylococci that would otherwise be resistant to standard penicillins. Lactic acid works through a different non-antibiotic mechanism. It acidifies the local environment, creating a pH that is unfavourable for the growth of pathogenic bacteria and fungi, particularly in the urogenital tract. Lactic acid also helps maintain the natural vaginal flora dominated by lactobacilli, which produce their own lactic acid as a defence mechanism. The combination of these three agents provides comprehensive coverage against common urogenital pathogens including Neisseria gonorrhoeae, Chlamydia trachomatis, Staphylococcus aureus, and mixed anaerobic infections, while lactic acid helps restore and maintain the physiological microenvironment.

Therapeutic Uses

This triple combination is primarily indicated for the treatment of mixed urogenital and gynecological infections:

• Vaginal Infections and Bacterial Vaginosis: The combination addresses both aerobic and anaerobic pathogens while lactic acid helps restore the natural acidic pH of the vaginal environment.
• Pelvic Inflammatory Disease: Provides broad coverage against the polymicrobial nature of upper genital tract infections including gonococcal, chlamydial, and anaerobic organisms.
• Post-Surgical Gynecological Infections: Used prophylactically and therapeutically for infections following gynecological procedures and surgeries.
• Mixed Urinary Tract Infections: Effective against complicated UTIs involving both Gram-negative bacilli and Gram-positive cocci.

Why Manufacturers Choose This Combination

Cefixime plus Cloxacillin plus Lactic Acid is a popular fixed-dose combination in the Indian gynecological and genitourinary market. The combination addresses the clinical reality that mixed infections involving both aerobic bacteria and disturbance of the vaginal flora are extremely common. Indian manufacturers produce this as vaginal tablets and suppositories, with the lactic acid component providing additional therapeutic value over simple antibiotic combinations. The combination is particularly popular in PCD franchise product lines targeting the gynecology specialty. This makes it one of the most sought-after combination products for third party manufacturing in India, with consistent demand from PCD franchise operators and export-oriented companies.